The cooperation continues between t...

The cooperation continues between the American Academy of Family Physicians (AAFP), the Advisory Committee upon Immunization Practices (ACIP), and the American body of Obstetricians and Gynecologists (ACOG) with the publication of the attract favor toed Adult Immunization Schedule, United States, 2003-2004 (Figures 1 and 2) This is the other year that a family physician has l the Working cluster on Adult Immunizations at the ACIP (Richard D Clover MD l the assemblage last year). The schedule, although similar to last year's schedule, has a certain number of changes in formatting, footnotes, and clarity of language. Annual updates to the schedule are planned.

common part of the schedule lists immunizations indicated through age, particularly influenza, tetanus and diphtheria toxoids, and pneumococcal polysaccharide vaccine. Fortunately, supplies for all of these vaccines are proper this year. A new live, attenuated influenza vaccine (LAIV; FluMist) for healthy living bodys five to 49 years of age should be available in addition to the older inactivated vaccine. A major advantage of LAIV is that it is administered intranasally. LAIV contains cold-adapted viruses that do not replicate well in the lower airways. However, exacerbations of asthma were noted after vaccination in more [i]or[/i] less age groups; thus, the safety of LAIV has not been established in ones with asthma. LAIV is contraindicated in immunodeficient somebodys The efficacy is good in children 60 to 84 month of age and in adults 18 to 49 years of age; hence, LAIV is licensed for healthy human frames five to 49 years of age; safety and efficacy have not been established in the somewhat advanced in life Although the optimal influenza vaccination season is October and November, inactivated influenza vaccine or LAIV can be given December by the agency of March for those who were not vaccinated during the fall. Vaccine information statements for influenza vaccines as well as all other routine vaccines can be downloaded delivered from http://www.cdc.gov/nip.

Several unravellings relate to pneumococcal polysaccharide vaccine. The payment on Medicare Part B for pneumococcal polysaccharide vaccine increased from $1310 to $1862 effective October 1 2003 Billing information for Medicare for influenza and pneumococcal vaccinations can be obtained at http://www.cms.hhs.gov/preventiveservices/ 2.asp. Influenza vaccination during the fall is a prime opportunity to assess pneumococcal polysaccharide vaccination status and check for indications for it. The Center for Medicare and Medicaid Services now allow the use of standing orders in hospitals to give influenza and pneumococcal polysaccharide vaccines.

The other part of the schedule lists immunizations indicated and contraindicated at medical conditions. Because the influenza mortality rate is primarily determined by the agency of the number of high-risk conditions, influenza vaccination of high-risk bodily forms and their close contacts is particularly important.

A elucidation development this year was publication of the revised edition of the Standards for Adult Immunization Practices, (1) which discusses ways to make secure optimal immunization of adults against vaccine-preventable diseases.

Information forward immunizations by family physician leaders for family physicians can be lay the foundation of at http://www. immunizationed.org, which includes exempt handheld personal digital assistant software in Palm and Windows formats and links to fresh articles on immunization. (2) Educational materials for case-based learning for residents and close examiners can be found at http://www.atpm.org/Immunization/TIME/body_time.html. Materials for offices about adult immunization can be establish at http://www. partnersforimmunization.org, http://www.immunize.org, http://www.cdc.gov/nip, http://www.nfid.org/ncai, http://www.immunizationinfo.org, and http://www.aafp.org.

REFERENCES

(1) Poland GA, Shefer AM, McCauley M Webster P Whitley-Williams PN Peter G National Vaccine Advisory Committee, Ad Hoc Working dispose for the Development of Standards for Adult Immunization Practices. Standards for adult immunization practices. Am J Prev M 2003;25:144-50

(2) Zimmerman RK Middleton DB chars IT, Clover RD. Routine vaccines across the life span, 2003 J Fam Pract 2003;52(1 suppl):S1-21

1 Tetanus and diphtheria (Td)--Adults, including pregnant women with uncertain histories of a entire primary vaccination series, should receive a primary series of Td A primary series for adults is 3 doses: the first 2 doses given at least 4 weeks apart and the third dose, 6 to 12 month after the inferior Administer 1 dose if the bodily substance had received the primary series and the last vaccination was 10 years ago or longer confer MMWR 1991;40(RR-10):1-21 for administering Td as prophylaxis in injury management. The American College of Physicians (ACP) Task Force upon Adult Immunization supports a secondary option for Td use in adults: a single Td booster at 50 years of age for human frames who have completed the sated pediatric series, including the teenage/young adult booster Guide for Adult Immunization. 3d ed ACP 1994:20.